CSF | |||||
---|---|---|---|---|---|
Patient no. | WBC (lymphocytes)/RBC per μl | Protein (g/l) | Viral DNA* | Intrathecal antibody synthesis | Seroconversion to IgG or IgM† |
1 | 7 (NT)/1310 | 0.8 | HSV‡ | NT | NT |
2 | 35 (35)/3500 | 0.55 | HSV‡ | NT | NT |
3 | 25 (25)/3 | 0.47 | HSV-1 | NT | NT |
4 | 23 (18)/<1 | 0.6 | Negative | NT | Yes |
5 | 93 (93)/295 | 0.5 | HSV-1 | NT | NT |
6 | 2 (NT)/12 | 0.68 | HSV‡ | NT | Yes |
7 | 560 (280)/900§ | 1.03 | HSV-1 | NT | NT |
8 | 7 (NT)/50 | 0.34 | HSV-1 | NT | NT |
9 | 70 (70)/40 | 0.32 | Negative | Yes | NT |
10 | 21 (21)/115 | 1.01 | HSV-1 | NT | NT |
11 | 97 (NK)/50¶ | 1.0 | HSV-1 | NT | NT |
12 | 120 (85)/2510 | NT | HSV-1 | NT | NT |
13 | NT | NT | NT | NT | Yes |
14 | <1 (<1)/50 | 0.23 | HSV-1 | NT | NT |
15 | <1 (<1)/<1 | NK | HSV-1 | NT | NT |
16 | 1 (1)/10 | 0.14 | HSV-1 | NT | NT |
17 | NK (NK)/NK | NK | HSV‡ | NT | NT |
18 | NT | NT | NT | NT | Yes |
19 | 10 (10)/37** | 1.06 | HSV‡ | NT | NT |
↵* Tested for by PCR.
↵† Within 2 weeks of onset of serious neurological disease.
↵‡ Virus not typed.
↵§ First CSF nothing abnormal detected.
↵¶ First CSF clotted.
* *First sample WBC <1/RBC per μl 127.
CNS, central nervous system; CSF, cerebrospinal fluid; HSV, herpes simplex virus; NK, not known; NT, not tested; RBC, red blood cell; WBC, white blood cell.